Prognostic Significance of Selected Lifestyle Factors in Urinary Bladder Cancer
Overview
Affiliations
To examine the prognostic significance of lifestyle factors in urinary bladder cancer, we conducted a follow-up study of 258 incident bladder cancer patients, who were originally recruited in a case-control study in metropolitan Nagoya. Information on individual survivals was obtained from the computer data-file of the tumor registry of the Nagoya Bladder Cancer Research Group. Univariate analyses revealed significant associations of 5-year survivorship with educational attainment, marital status, drinking habits and consumption of green tea in males, and age at first consultation, histological type and grade of tumor, stage and distant metastasis in both sexes. After adjustment for age, stage, histology (histological type and grade) and distant metastasis by means of a proportional hazards model, drinking of alcoholic beverages was significantly associated with the prognosis of bladder cancer in males. Its adjusted hazard ratio was 0.46 (95% confidence interval: 0.26-0.79), favoring patients who had taken alcoholic beverages. In detailed analysis, ex-drinkers and all levels of current drinkers demonstrated hazard ratios smaller than unity, although no clear dose-response relationship was detected. No prognostic significance was found for such lifestyle factors as smoking habit, uses of artificial sweeteners and hairdye, and consumption of coffee, black tea, matcha (powdered green tea) and cola.
Xiang L, Xie Q, Xu S, Ruan W, Xu D, Gan Y World J Methodol. 2024; 14(2):91889.
PMID: 38983655 PMC: 11229875. DOI: 10.5662/wjm.v14.i2.91889.
van Hoogstraten L, Vrieling A, van der Heijden A, Kogevinas M, Richters A, Kiemeney L Nat Rev Clin Oncol. 2023; 20(5):287-304.
PMID: 36914746 DOI: 10.1038/s41571-023-00744-3.
Zuniga K, Graff R, Feiger D, Meng M, Porten S, Kenfield S Bladder Cancer. 2021; 6(1):9-23.
PMID: 34095407 PMC: 8174672. DOI: 10.3233/blc-190249.
Green tea (Camellia sinensis) for the prevention of cancer.
Filippini T, Malavolti M, Borrelli F, Izzo A, Fairweather-Tait S, Horneber M Cochrane Database Syst Rev. 2020; 3:CD005004.
PMID: 32118296 PMC: 7059963. DOI: 10.1002/14651858.CD005004.pub3.
Westhoff E, Witjes J, Fleshner N, Lerner S, Shariat S, Steineck G Bladder Cancer. 2018; 4(1):91-112.
PMID: 29430510 PMC: 5798521. DOI: 10.3233/BLC-170147.